| Bioactivity | 2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine |
| CAS | 37805-86-0 |
| Formula | C31H26N2O10 |
| Molar Mass | 586.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. |
2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine
CAS: 37805-86-0 F: C31H26N2O10 W: 586.55
2’,3’,5’-Tri-O-benzoyl-5-methoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.